Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

The New England journal of medicine·2026
Same author

Targeting Interleukin-8-Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome.

Circulation·2026
Same author

Models of the human heart for biomedical research: Opportunities and challenges.

Physiological reports·2026
Same author

Outcomes of transcatheter edge-to-edge repair versus transcatheter valve replacement with the cardiovalve system for tricuspid regurgitation.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Transmural breakthrough and epicardial growth of right atrial myxoma: a case report.

European heart journal. Case reports·2025
Same author

A heart failure network model to improve outcome and trans-sectoral guideline-directed medical treatment utilization.

ESC heart failure·2025
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
Same journal

Beyond the ICD: Navigating Ventricular Tachycardia Suppression Strategies in the Modern Era.

Current cardiology reports·2026
See all related articles

Related Experiment Video

Updated: Feb 25, 2026

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.6K

Myocardial Tissue Engineering for Regenerative Applications.

Buntaro Fujita1,2,3, Wolfram-Hubertus Zimmermann4,5

  • 1Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Current Cardiology Reports
|July 29, 2017
PubMed
Summary
This summary is machine-generated.

Tissue-engineered heart repair advances remuscularization and paracrine support for cardiac repair. Strategies are progressing towards clinical trials, focusing on immune compatibility for long-term graft retention.

Keywords:
Engineered heart muscleHeart failurePluripotent stem cellsRegenerationRemuscularizationTissue engineeringTransplant immunology

More Related Videos

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
09:24

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

15.2K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.1K

Related Experiment Videos

Last Updated: Feb 25, 2026

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.6K
Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
09:24

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

15.2K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.1K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Myocardial tissue engineering has seen significant progress, with various strategies advancing towards clinical application.
  • Effective heart repair necessitates either remuscularization via cardiomyocyte delivery or paracrine support to stimulate endogenous repair mechanisms.

Purpose of the Study:

  • To review the current status of tissue-engineered heart repair.
  • To examine the mechanisms of action for tissue-engineered therapies.
  • To discuss implications for transplant immunology.

Main Methods:

  • Review of current scientific literature and pre-clinical/clinical studies on myocardial tissue engineering.
  • Analysis of strategies for cardiomyocyte delivery, paracrine support, and graft retention.
  • Evaluation of immunological challenges and solutions for tissue-engineered heart repair.

Main Results:

  • Tissue engineering enhances cardiomyocyte retention and remuscularization, offering potential for paracrine or mechanical support.
  • Advanced approaches are in clinical testing or late pre-clinical stages, requiring cGMP-compatible processes for scalability.
  • Long-term allograft retention is achievable with immunosuppression; HLA matching may reduce its intensity.

Conclusions:

  • Tissue-engineered heart repair is entering the clinical phase, with immunosuppression and allograft implantation as likely scenarios.
  • Anticipating and managing side effects is crucial for therapeutic success.
  • Evolving strategies to mitigate transplant rejection will enhance clinical acceptance.